Clovis Oncology

Oncology Compound Licencing Company

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets.

Founded in 2009
Homepage: http://clovisoncology.com
Total money raised: $145M

HQ

80301 2525 28th Street
Suite 100
Boulder
USA CO

Updated on Mar 31, 2013
Clovis Oncology at CrunchBase

Patrick Mahaffy co-founder, CEO & President
Brian Atwood Board Member
Past

January, 2012

Clovis Oncology invested $4M in Avila Therapeutics as unattributed round

November, 2011

Clovis Oncology IPO
Stock symbol: NASDAQ:CLVS

May, 2009

Clovis Oncology raised $145M in a Series A round from Domain Associates, New Enterprise Associates, Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures, and ProQuest Investments

Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development

onbiovc.com

2009

Clovis Oncology was founded in 2009

BuzzSparks.org Timeline Analytics News